ATE262315T1 - Stabilisiertes wässriges flüssiges blutgerinnungsfaktor xiii-präparat - Google Patents

Stabilisiertes wässriges flüssiges blutgerinnungsfaktor xiii-präparat

Info

Publication number
ATE262315T1
ATE262315T1 AT96109167T AT96109167T ATE262315T1 AT E262315 T1 ATE262315 T1 AT E262315T1 AT 96109167 T AT96109167 T AT 96109167T AT 96109167 T AT96109167 T AT 96109167T AT E262315 T1 ATE262315 T1 AT E262315T1
Authority
AT
Austria
Prior art keywords
aqueous liquid
factor xiii
stabilized aqueous
blood clotting
clotting factor
Prior art date
Application number
AT96109167T
Other languages
English (en)
Inventor
Naoko Kato
Shuji Kondo
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of ATE262315T1 publication Critical patent/ATE262315T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT96109167T 1995-06-05 1996-06-03 Stabilisiertes wässriges flüssiges blutgerinnungsfaktor xiii-präparat ATE262315T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7137863A JPH08333277A (ja) 1995-06-05 1995-06-05 ヒト血液凝固第ｘｉｉｉ因子の安定化された水性液製剤

Publications (1)

Publication Number Publication Date
ATE262315T1 true ATE262315T1 (de) 2004-04-15

Family

ID=15208515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96109167T ATE262315T1 (de) 1995-06-05 1996-06-03 Stabilisiertes wässriges flüssiges blutgerinnungsfaktor xiii-präparat

Country Status (9)

Country Link
US (1) US6084074A (de)
EP (1) EP0754463B1 (de)
JP (1) JPH08333277A (de)
AT (1) ATE262315T1 (de)
AU (1) AU722743B2 (de)
CA (1) CA2178144C (de)
DE (1) DE69631930T2 (de)
DK (1) DK0754463T3 (de)
ES (1) ES2213759T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
US6447774B1 (en) * 1998-11-18 2002-09-10 Aventis Behring Gmbh Stabilized protein preparations for a tissue adhesive
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
WO2002011753A1 (en) * 2000-08-04 2002-02-14 Chugai Seiyaku Kabushiki Kaisha Protein injection preparations
US20040014657A1 (en) * 2001-11-05 2004-01-22 Jan Ohrstrom Use of blood coagulation factor XIII for treating haemophilia A
US20040033947A1 (en) * 2001-11-08 2004-02-19 Jan Ohrstrom Method for treating hemophilia b
PT1954308E (pt) * 2005-09-16 2011-11-03 Merial Ltd Estabilizadores para vacinas liofilizadas
HUE037932T2 (hu) 2007-09-14 2018-09-28 Sanofi Pasteur Biologics Llc Clostridium difficile A és B toxoidjait tartalmazó gyógyászati kompozíciók
JP6244079B2 (ja) 2008-04-21 2017-12-06 ノボ ノルディスク ヘルス ケア アーゲー 乾燥トランスグルタミナーゼ組成物
CA2742659C (en) 2008-11-04 2016-09-27 Aska Pharmaceutical Co., Ltd. Aqueous composition containing follicle-stimulating hormone
SI2741740T1 (sl) 2011-08-12 2017-08-31 Merial, Inc. Vakuumsko konzerviranje bioloških proizvodov, zlasti cepiv
WO2019182123A1 (ja) * 2018-03-23 2019-09-26 味の素株式会社 トランスグルタミナーゼを含有する液体製剤
CN111500563B (zh) * 2020-05-08 2023-10-13 华兰生物工程重庆有限公司 一种从人血浆中纯化人凝血因子ⅶ的方法
WO2025013783A1 (ja) * 2023-07-07 2025-01-16 ナガセヴィータ株式会社 タンパク質の変性抑制用組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
US5204447A (en) * 1988-11-14 1993-04-20 Zymogenetics, Inc. Purification of factor xiii
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
AU665805B2 (en) * 1992-01-22 1996-01-18 Novo Nordisk A/S Activated factor XIII
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
EP0754463A3 (de) 1999-02-03
EP0754463A2 (de) 1997-01-22
AU5472896A (en) 1996-12-19
DE69631930D1 (de) 2004-04-29
CA2178144C (en) 2008-06-03
EP0754463B1 (de) 2004-03-24
US6084074A (en) 2000-07-04
CA2178144A1 (en) 1996-12-06
AU722743B2 (en) 2000-08-10
ES2213759T3 (es) 2004-09-01
DK0754463T3 (da) 2004-06-28
DE69631930T2 (de) 2005-01-27
JPH08333277A (ja) 1996-12-17

Similar Documents

Publication Publication Date Title
ATE262315T1 (de) Stabilisiertes wässriges flüssiges blutgerinnungsfaktor xiii-präparat
NO993709D0 (no) Stabilisert blanding omfattende fibrinogen
DE69718612D1 (de) Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendung
DE68901140D1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
ATE82510T1 (de) Verfahren zur inaktivierung von viren.
EP0838221A4 (de) Lyophilisierte hgf-zubereitungen
KR930005633A (ko) 성장인자 및 고분자 전해질을 함유하는 조합체
ATE185488T1 (de) Virussichere blutgerinnungsfaktor xiii- präparation
DE68908913D1 (de) Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.
EP0651655A4 (de) Blockierung der protein c aktivierung reduziert den blutverlust in mikrogefässen bei chirurgischen eingriffen.
WO1994002611A3 (en) Recombinant human erythropoietin with altered biological activity
ATE322906T1 (de) Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten
ATE271125T1 (de) Neuartige tyrosinkinase
DK0431465T3 (da) Vandig dialyse- og skylleopløsning
DE69227607D1 (de) Arzneimittel auf Basis von Hyaluronsäure
EP0239644A4 (de) Neue physiologisch aktive mittel mit blutkoagulierungsregelnder wirkung.
FI98891B (fi) Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi
DK312889D0 (da) Vaeske til konditionering af tand- eller knoglesubstanser, deres fremstilling og anvendelse
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.
CY1106882T1 (el) Τροποποιηση βητακυτταρουλινης
EP0508435A3 (en) Pharmaceutical composition of stabilized (leu 13)-motilin-hse
DE69535224D1 (de) Vorrichtung und gel zur säurepufferung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0754463

Country of ref document: EP